Live feed
Filing
SC 13D/A
SC 13D/A0000947871-24-000303·Compass Therapeutics, Inc.
Schedule 13D ownership disclosure
Compass Therapeutics Inc
Security class unavailable · CUSIP: 20454B104
Event date: 2024-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-000303
- Form type
- SC 13D/A
- Filer
- Compass Therapeutics, Inc.
- CIK
- CIK 1738021
- Filed
- Mar 22, 2024
- Reporting period
- Mar 21, 2024
- Description
- Schedule 13D beneficial ownership